HYDROXYZINE PAMOATE (HYDROXYZINE PAMOATE) — FDA Approval ANDA081165 (WATSON LABS)
HYDROXYZINE PAMOATE (HYDROXYZINE PAMOATE) — FDA Approval ANDA081165 (WATSON LABS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HYDROXYZINE PAMOATE; Active ingredients: HYDROXYZINE PAMOATE; Application number: ANDA081165.
| Brand name | HYDROXYZINE PAMOATE |
|---|---|
| Active ingredients | HYDROXYZINE PAMOATE |
| Application number | ANDA081165 |
| Sponsor | WATSON LABS |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19910731 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →